Clinical Trial Update: Safety and Efficacy of Co-Administration of Sitagliptin and Metformin in China (MK-0431-121) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of co-administered sitagliptin and metformin in China for type 2 diabetes completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Januvia (sitagliptin)
• metformin (metformin)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2014-02-06